🤯 Have you seen our AI stock pickers’ 2024 results? 84.62%! Grab November’s list now.Pick Stocks with AI

Haemonetics to report Q3 fiscal 2024 results on February 8

EditorAhmed Abdulazez Abdulkadir
Published 01/12/2024, 05:38 AM
© Reuters.
HAE
-

BOSTON - Haemonetics Corporation (NYSE: NYSE:HAE), a global healthcare company, has scheduled the release of its third quarter fiscal year 2024 financial results for early morning on February 8, 2024. Following the announcement, the company will host a conference call with investors and analysts at 8:00 am ET to discuss the quarterly outcomes and field questions.

Participants interested in joining the conference call can register for the teleconference, which will provide them with a personalized PIN for access.

Additionally, a live webcast of the conference call will be available on the investor relations section of Haemonetics' website. For those unable to attend the live event, a replay will be accessible starting at 11:00 am ET on the day of the call and will remain available for one year.

Haemonetics is known for its medical products and solutions that focus on blood and plasma component collection, the surgical suite, and hospital transfusion services. These technologies are designed to enhance patient care while aiming to reduce healthcare costs.

This announcement is based on a press release statement from Haemonetics Corporation.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.